To assess the virological, immunological and metabolic effects of switching from an efficacious first-line protease inhibitor (PI)-based HAART to a simplified triple nucleoside reverse transcriptase inhibitor (NRTI) regimen in children vertically infected with HIV.
Palma, P., Romiti, M.l., Cancrini, C., Pensieroso, S., Montesano, C., Santucci, M.b., et al. (2007). Successful simplification of protease inhibitor-based HAART with triple nucleoside regimens in children vertically infected with HIV. AIDS, 21(18), 2465-2472 [10.1097/QAD.0b013e3282f1560b].
Successful simplification of protease inhibitor-based HAART with triple nucleoside regimens in children vertically infected with HIV
Palma, P;ROMITI, MARIA LUISA;CANCRINI, CATERINA;MONTESANO, CARLA;SANTUCCI, MARILINA BENEDETTA;ROSSI, PAOLO;
2007-11-30
Abstract
To assess the virological, immunological and metabolic effects of switching from an efficacious first-line protease inhibitor (PI)-based HAART to a simplified triple nucleoside reverse transcriptase inhibitor (NRTI) regimen in children vertically infected with HIV.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Questo articolo è pubblicato sotto una Licenza Licenza Creative Commons
